Guardant Health Overview
Guardant Health Target Price
Analysts' 12-month price predictions for GH.
Get informed when a big investor buys or sells
+ FollowShare Price
$160.11
Average Target Price
$163.47
2.1% upside
2.1% upside15 analysts in the last 4 months
High: $200 | Low: $115
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-09 | Morgan Stanley | $175 | 9.3% upside |  |
| 2026-07-06 | Evercore ISIVijay Kumar | $200 | 24.9% upside | |
| 2026-07-02 | BernsteinEve Burstein | $200 | 24.9% upside | |
| 2026-07-01 | BTIG | $190 | 18.7% upside | |
| 2026-06-29 | Guggenheim | $160 |  0.1% downside | |
| 2026-06-24 | UBS | $150 | 6.3% downside | |
| 2026-06-11 | RBC CapitalDan Leonard | $185 | 15.5% upside | |
| 2026-06-08 | Mizuho Securities | $175 | 9.3% upside | |
| 2026-06-05 | Goldman SachsEvie Koslosky | $165 | 3.1% upside | |
| 2026-06-02 | Evercore ISI | $160 | 0.1% downside | |
| 2026-05-27 | BTIG | $160 | 0.1% downside | |
| 2026-05-26 | BTIGMark Massaro | $155 | 3.2% downside | |
| 2026-05-21 | Piper Sandler | $127 | 20.7% downside | |
| 2026-05-12 | Piper SandlerDavid Westenberg | $135 | 15.7% downside | |
| 2026-04-14 | BarclaysLuke Sergott | $115 | 28.2% downside | |
| 2026-02-24 | Piper Sandler | $130 | 18.8% downside | |
| 2026-02-23 | Raymond James | $129 | 19.4% downside | |
| 2026-02-20 | Evercore ISI | $110 | 31.3% downside | |
| 2026-02-20 | BTIG | $145 | 9.4% downside | |
| 2026-02-20 | Stifel Nicolaus | $130 | 18.8% downside | |
| 2026-02-20 | Canaccord Genuity | $135 | 15.7% downside | |
| 2026-02-20 | Barclays | $130 | 18.8% downside | |
| 2026-02-17 | Robert W. BairdCatherine Schulte | $120 | 25.1% downside | |
| 2026-01-30 | UBS | $175 | 9.3% upside | |
| 2026-01-26 | Guggenheim | $135 | 15.7% downside | |
| 2026-01-09 | Stifel Nicolaus | $120 | 25.1% downside | |
| 2026-01-09 | Mizuho Securities | $135 | 15.7% downside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $115 | 28.2% downside | |
| 2026-01-05 | Evercore ISIVijay Kumar | $105 | 34.4% downside | |
| 2025-12-22 | Canaccord Genuity | $125 | 21.9% downside | |
| 2025-12-17 | Mizuho Securities | $120 | 25.1% downside | |
| 2025-12-15 | Leerink Partners | $155 | 3.2% downside | |
| 2025-12-15 | Wells FargoBrandon Couillard | $120 | 25.1% downside | |
| 2025-12-15 | Barclays | $120 | 25.1% downside | |
| 2025-12-12 | BTIG | $140 | 12.6% downside | |
| 2025-12-01 | Morgan StanleyTejas Savant | $130 | 18.8% downside | |
| 2025-10-30 | UBSDan Leonard | $110 | 31.3% downside | |
| 2025-10-30 | BTIGMark Massaro | $100 | 37.5% downside | |
| 2025-10-30 | Mizuho SecuritiesBradley Bowers | $100 | 37.5% downside | |
| 2025-10-30 | Canaccord GenuityKyle Mikson | $100 | 37.5% downside | |
| 2025-10-30 | Barclays | $85 | 46.9% downside | |
| 2025-10-22 | Piper Sandler | $90 | 43.8% downside | |
| 2025-10-02 | Barclays | $70 | 56.3% downside | |
| 2025-09-26 | Canaccord GenuityKyle Mikson | $75 | 53.2% downside | |
| 2025-09-25 | Stifel Nicolaus | $70 | 56.3% downside | |
| 2025-09-25 | BTIGMark Massaro | $80 | 50% downside | |
| 2025-09-25 | Stifel NicolausDaniel Arias | $73 | 54.4% downside | |
| 2025-09-25 | Wolfe ResearchDoug Schenkel | $75 | 53.2% downside | |
| 2025-06-25 | China Renaissance Securities (US) Inc.Tempus AI | $70 | 56.3% downside | |
| 2025-03-05 | Morgan Stanley | $52 | 67.5% downside | |